SyntekaBio Inc (226330) — Financial Flexibility Index
SyntekaBio Inc (226330) has a Financial Flexibility Index of -0.17x as of March 2026. Free cash flow of ₩-2.59 Billion (operating CF ₩-2.77 Billion minus capex ₩176.44 Million) represents 0% of total liabilities (₩15.35 Billion). Check 226330 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SyntekaBio Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for SyntekaBio Inc across 9 annual periods. For the full cash flow conversion analysis, see SyntekaBio Inc cash flow conversion.
Annual Financial Flexibility Index for SyntekaBio Inc (2017–2025)
Year-by-year free cash flow to debt coverage for SyntekaBio Inc. Explore 226330 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.72x | ₩-10.57 Billion | ₩-10.65 Billion | ₩14.76 Billion | ▼ -186.5% |
| 2024 | -0.25x | ₩-4.69 Billion | ₩-10.51 Billion | ₩18.77 Billion | ▼ -501.1% |
| 2023 | 0.06x | ₩1.35 Billion | ₩-8.08 Billion | ₩21.69 Billion | ▲ +514.1% |
| 2022 | 0.01x | ₩245.87 Million | ₩-8.51 Billion | ₩24.23 Billion | ▼ -71.6% |
| 2021 | 0.04x | ₩1.44 Billion | ₩-6.04 Billion | ₩40.25 Billion | ▲ +103.0% |
| 2020 | -1.20x | ₩-3.88 Billion | ₩-4.67 Billion | ₩3.24 Billion | ▲ +9.9% |
| 2019 | -1.33x | ₩-2.44 Billion | ₩-3.28 Billion | ₩1.84 Billion | ▼ -711.2% |
| 2018 | -0.16x | ₩-1.71 Billion | ₩-2.37 Billion | ₩10.47 Billion | ▲ +64.2% |
| 2017 | -0.46x | ₩-2.42 Billion | ₩-2.49 Billion | ₩5.29 Billion | — |